Clinical Trial Update: AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease [Phase 1]

View source ↗

Summary

AU409 is being evaluated in a Phase 1 trial for advanced cholangiocarcinoma and hepatocellular carcinoma, including patients with stage III/IV disease and liver…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Hepatocellular Carcinoma

Drugs mentioned

• AU409

Snippet

Sponsor: University of Southern California | Conditions: Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma | Phase 1 | Status: RECRUITING